share_log

Dynatrace (NYSE:DT) Coverage Initiated at JPMorgan Chase & Co.

kopsource ·  Oct 5, 2022 02:31

Stock analysts at JPMorgan Chase & Co. started coverage on shares of Dynatrace (NYSE:DT – Get Rating) in a research report issued to clients and investors on Monday, The Fly reports. The brokerage set an "overweight" rating on the stock.

Several other research analysts have also weighed in on DT. Needham & Company LLC increased their price objective on Dynatrace from $42.00 to $50.00 and gave the stock a "buy" rating in a research report on Thursday, August 4th. Canaccord Genuity Group initiated coverage on Dynatrace in a research report on Friday, July 8th. They issued a "buy" rating and a $55.00 price objective for the company. Moffett Nathanson initiated coverage on Dynatrace in a research report on Thursday, September 22nd. They issued a "hold" rating and a $52.00 price objective for the company. Robert W. Baird reiterated an "outperform" rating and issued a $49.00 price objective on shares of Dynatrace in a research report on Wednesday, September 21st. Finally, Truist Financial lowered their price objective on Dynatrace from $60.00 to $57.00 and set a "buy" rating for the company in a research report on Monday, July 18th. Four equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $57.68.

Get Dynatrace alerts:

Dynatrace Price Performance

DT stock opened at $38.19 on Monday. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.15 and a quick ratio of 1.15. The business has a 50 day simple moving average of $38.54 and a 200-day simple moving average of $39.71. The firm has a market capitalization of $10.97 billion, a PE ratio of 272.79, a price-to-earnings-growth ratio of 5.00 and a beta of 1.25. Dynatrace has a 1 year low of $29.41 and a 1 year high of $80.13.

Dynatrace (NYSE:DT – Get Rating) last posted its quarterly earnings results on Wednesday, August 3rd. The company reported $0.08 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.08. The business had revenue of $267.27 million during the quarter, compared to analyst estimates of $262.76 million. Dynatrace had a return on equity of 7.81% and a net margin of 4.18%. Equities research analysts anticipate that Dynatrace will post 0.36 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CRO Stephen J. Pace sold 26,303 shares of the firm's stock in a transaction dated Thursday, September 8th. The stock was sold at an average price of $40.00, for a total transaction of $1,052,120.00. Following the transaction, the executive now owns 137,378 shares of the company's stock, valued at $5,495,120. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In related news, CRO Stephen J. Pace sold 26,303 shares of the firm's stock in a transaction dated Thursday, September 8th. The shares were sold at an average price of $40.00, for a total value of $1,052,120.00. Following the completion of the sale, the executive now owns 137,378 shares in the company, valued at $5,495,120. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CRO Stephen J. Pace sold 4,281 shares of the firm's stock in a transaction dated Tuesday, August 16th. The shares were sold at an average price of $42.42, for a total transaction of $181,600.02. Following the completion of the sale, the executive now owns 164,963 shares of the company's stock, valued at approximately $6,997,730.46. The disclosure for this sale can be found here. Insiders have sold a total of 66,029 shares of company stock valued at $2,639,297 over the last quarter. 0.51% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Dynatrace

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. lifted its position in shares of Dynatrace by 0.3% during the 1st quarter. Vanguard Group Inc. now owns 18,419,894 shares of the company's stock valued at $867,577,000 after acquiring an additional 46,888 shares during the period. Brown Advisory Inc. raised its position in shares of Dynatrace by 8.7% during the 2nd quarter. Brown Advisory Inc. now owns 12,284,047 shares of the company's stock worth $490,004,000 after purchasing an additional 982,941 shares during the last quarter. Dragoneer Investment Group LLC raised its position in shares of Dynatrace by 49.1% during the 1st quarter. Dragoneer Investment Group LLC now owns 7,149,440 shares of the company's stock worth $336,739,000 after purchasing an additional 2,355,247 shares during the last quarter. William Blair Investment Management LLC raised its position in shares of Dynatrace by 31.0% during the 1st quarter. William Blair Investment Management LLC now owns 6,989,994 shares of the company's stock worth $329,229,000 after purchasing an additional 1,653,151 shares during the last quarter. Finally, SRS Investment Management LLC raised its position in shares of Dynatrace by 13.4% during the 1st quarter. SRS Investment Management LLC now owns 4,248,406 shares of the company's stock worth $200,100,000 after purchasing an additional 501,602 shares during the last quarter. 94.70% of the stock is currently owned by institutional investors and hedge funds.

About Dynatrace

(Get Rating)

Dynatrace, Inc provides a software intelligence platform for dynamic multi-cloud environments. It operates Dynatrace, a software intelligence platform, which provides application and microservices monitoring, runtime application security, infrastructure monitoring, digital experience monitoring, business analytics, and cloud automation.

Read More

  • Get a free copy of the StockNews.com research report on Dynatrace (DT)
  • Don't Give Up on These Q3 Losers
  • The Anatomy of a Great Pension Plan
  • 3 Safe Earnings Plays for a Risk-Off Market
  • Tyson Foods Takes a Lickin' and Keeps on Tickin' Lower
  • Small-Cap Catalyst Pharma Is Among Market's Best Price Performers

Receive News & Ratings for Dynatrace Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatrace and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment